Hiab Corporation HIAB CORPORATION, STOCK EXCHANGE RELEASE, 19 FEBRUARY 2026 AT 8:00 AM (EET) Hiab publishes its 2025 annual report and financial statementsHiab Corporation’s 2025 annual report and financial statements for the financial year 1 January–31 December 2025 have been published in English and Finnish. The report consists of the annual review, financial review, corporate

As global markets grapple with AI disruption concerns and shifting economic indicators, the Asian stock markets present a unique landscape of opportunities. In this environment, identifying stocks that are trading below their intrinsic value can be particularly appealing to investors seeking potential growth amid broader market volatility. Name Current Price Fair Value (Est) Discount (Est)

It isn’t easy to cope with alleged dumping on a company’s key markets. Numerous investors considered specialty metals and alloys company Ferroglobe (NASDAQ: GSM) a special stock on Wednesday. Following the release of its latest earnings report, an obviously pleased market snapped up the company’s shares to power them to a more than 4% gain

The self-storage REIT has fallen behind in recent years. CubeSmart (CUBE 0.44%) is the country’s third-largest self-storage property company with over 1,500 locations. While self-storage REITs have historically been strong performers over multiple decades, CubeSmart hasn’t beaten the market over the past 10 years (and underperformed its largest rival during the time frame). It has

The S&P 500 delivered strong returns for investors over the past three years as they piled into growth stocks in a number of fields, from technology to biotech and consumer goods. And they took a particular interest in players involved in artificial intelligence (AI), seeing this area as the next big thing. This bet has

SASKATOON, Saskatchewan, February 18, 2026–(BUSINESS WIRE)–Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors declared a quarterly dividend of US$0.55 per share payable on April 16, 2026 to shareholders of record on March 31, 2026. This represents an approximately one percent increase from the prior dividend declared on November 5, 2025

On Feb. 18, 2026, investors weighed ImmunityBio’s EU bladder cancer win against its long slide since IPO and fresh legal scrutiny. Today’s Change (41.36%) $2.49 Current Price $8.51 Key Data Points Market Cap $5.9B Day’s Range $6.08 – $8.68 52wk Range $1.83 – $8.68 Volume 2.5M Avg Vol 27M Gross Margin 80.41% ImmunityBio (IBRX +41.36%),

(Image credit: Getty Images) Stocks opened up and stayed up, even under late selling pressure, amid more strong earnings and incoming economic data that continues to support Federal Reserve Chair Jerome Powell’s wait-and-see approach to interest rates. Risk-on sectors led the way higher, as the Nasdaq Composite posted the biggest gain among the three main

As the Australian stock market experiences a positive trend, buoyed by a robust February reporting season and modest gains on Wall Street, investors are keenly observing potential opportunities among undervalued stocks. In this environment, identifying stocks trading below their estimated intrinsic value can be particularly appealing for those looking to capitalize on favorable market conditions.

UiPath (NYSE: PATH), a developer of software robots, trades at about $11 per share. That’s 80% below its 2021 IPO price of $56. Its stock collapsed as its growth cooled, but could it bounce back and deliver millionaire-making gains? Image source: Getty Images. Will AI create the world’s first trillionaire? Our team just released a report

We recently published 17 Stocks Jim Cramer Talked About.  Thomson Reuters Corporation (NASDAQ:TRI) is one of the stocks that Jim Cramer talked about. Thomson Reuters Corporation (NASDAQ:TRI) is a legal, professional services, and news media company. The shares are down by 49% over the past year and by 31% year-to-date. RBC Capital upgraded the shares

If the stock market starts getting bearish, consider these ETFs to provide portfolio protection, risk mitigation, and even a positive performance. The markets have turned more nervous in 2026. What started out as a rotation out of tech and into more defensive and value-oriented areas of the market has turned into a steeper sell-off of

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. FINALLY. The Return of the Stock Picker’s Market The U.S. equity market may look steady on the surface but rising dispersion and falling correlations among S&P 500 stocks reveal a far more dynamic environment beneath.

(Bloomberg) — It’s been nearly 20 years since Apple Inc. was this untethered from its tech peers, giving investors an appealing alternative to the artificial intelligence-fueled volatility that has gripped most other corners of the stock market in recent weeks. Apple’s 40-day correlation to the Nasdaq 100 Index tumbled to 0.21 last week, the lowest

For most of the time since the pandemic, large-cap stocks have outperformed their smaller counterparts in the US stock market. That is, the LargeCap S&P 500 index has outperformed the MidCap S&P 400 and SmallCap S&P 600, collectively the “SMidCaps.” That started to change late last year as investors increasingly concluded that the former’s earnings outlook had become riskier and its

Could the largest U.S. tax increase as a percentage of GDP in 33 years affect the stock market? Yes. Open your pocketbooks. You’re about to pay up for President Trump’s tariffs this year. That’s the overriding message from a recent report published by the Tax Foundation, a nonpartisan organization focused on tax policy. The impact

The rapid acceleration in this company’s revenue growth can make this AI stock a multibagger. Nebius Group (NBIS 0.55%) is an important player in the artificial intelligence (AI) ecosystem, supplying the much-needed computing capacity to companies looking to train and deploy AI models and applications in the cloud. Nebius operates dedicated AI data centers equipped